Sage Therapeutics Inc SAGE

NAS: SAGE | ISIN: US78667J1088 30/04/2025

7,290 USD (-4,08%)

(-4,08%) 30/04/2025

Grafiek Sage Therapeutics Inc

Grafiek Sage Therapeutics Inc

1 dag1d -4,08%
1 week1w -6,42%
1 maand1m -7,25%
3 maanden3m 0,41%
6 maanden6m 20,50%
1 jaar1j -45,11%
5 jaar5j -80,37%

Sage Therapeutics Inc in het nieuws

Toon enkel gratis nieuws

29 maart 2025 · SAGE THERAPEUTICS INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Sage Therapeutics, Inc. - SAGE · Persbericht

13 september 2024 · SAGE Investors Have Opportunity to Lead Sage Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm · Persbericht

13 september 2024 · Investors who lost money on Sage Therapeutics, Inc.(SAGE) should contact Levi & Korsinsky about pending Class Action - SAGE · Persbericht

10 september 2024 · Sage Therapeutics, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - SAGE · Persbericht

19 augustus 2023 · SAGE INVESTIGATION NOTICE: Robbins Geller Rudman & Dowd LLP Announces Investigation into Sage Therapeutics, Inc. and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm · Persbericht

Profiel Sage Therapeutics Inc

Fabricage van farmaceutische preparaten

Farmaceutische producten: Andere

Gezondheidstechnologie

Website: www.sagerx.com

Hoofdzetel: Cambridge, Massachusetts Verenigde Staten

CEO: Jeffrey Jonas

Werknemers: 780

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe